Changmao Biochemical Engineering Company Limited Stock

Equities

954

CNE100000106

Commodity Chemicals

Market Closed - Hong Kong S.E. 04:08:35 2024-04-19 am EDT 5-day change 1st Jan Change
0.4 HKD +2.56% Intraday chart for Changmao Biochemical Engineering Company Limited -1.23% -32.20%

Financials

Sales 2021 548M 75.68M 593M Sales 2022 730M 101M 790M Capitalization 327M 45.23M 354M
Net income 2021 58M 8.01M 62.75M Net income 2022 81M 11.19M 87.63M EV / Sales 2021 0.59 x
Net Debt 2021 30.63M 4.23M 33.13M Net Debt 2022 228M 31.47M 247M EV / Sales 2022 0.76 x
P/E ratio 2021
5.03 x
P/E ratio 2022
4.02 x
Employees 631
Yield 2021 *
-
Yield 2022
12.5%
Free-Float 32.37%
More Fundamentals * Assessed data
Dynamic Chart
Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Changmao Biochemical Engineering to Swing to Loss in 2023 MT
Changmao Biochemical Engineering Company Limited Provides Earnings Guidance for the Year December 31, 2023 CI
Changmao Biochemical Unit Seeks 200 Million Yuan Bank Loan to Boost Factory Capacity MT
Changmao Biochemical Engineering’s Profit Down 90% in H1 MT
Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Changmao Biochemical Engineering's Profit to Drop in H1 MT
Changmao Biochemical Engineering Company Limited Provides Consolidated Net Profit Attributable Guidance for the Six Months Ended 30 June 2023 CI
Changmao Biochemical Engineering Company Limited approves Final Dividend for the Year Ended 31 December 2022, Payable on 18 July 2023 CI
Changmao Biochemical Engineering Company Limited Recommends Final Dividend for the Year Ended 31 December 2022, Payable on 18 July 2023 CI
Changmao Biochemical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Changmao Biochemical Engineering Company Limited Announces Change of Chairman of Remuneration and Appraisal Committee CI
Changmao Biochemical Sees Rise in FY22 Profit MT
Changmao Biochemical Engineering Company Limited Provides Earnings Guidance for the Year 2022 CI
Changmao Biochemical Engineering Eyes Secondary Listing in Shenzhen MT
More news
1 day+2.56%
1 week-1.23%
Current month-1.23%
1 month+6.67%
3 months-28.57%
6 months-25.93%
Current year-32.20%
More quotes
1 week
0.38
Extreme 0.375
0.40
1 month
0.36
Extreme 0.36
0.42
Current year
0.36
Extreme 0.36
0.61
1 year
0.36
Extreme 0.36
1.15
3 years
0.36
Extreme 0.36
1.15
5 years
0.36
Extreme 0.36
1.15
10 years
0.36
Extreme 0.36
1.65
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 93-07-31
Founder 67 92-12-02
Director/Board Member 49 12-03-31
Members of the board TitleAgeSince
Founder 67 92-12-02
Director/Board Member 81 92-11-30
Director/Board Member 62 01-05-31
More insiders
Date Price Change Volume
24-04-19 0.4 +2.56% 2 708 000
24-04-18 0.39 0.00% 0
24-04-17 0.39 0.00% 0
24-04-16 0.39 +2.63% 200,000
24-04-15 0.38 -9.52% 668,000

Delayed Quote Hong Kong S.E., April 19, 2024 at 04:08 am EDT

More quotes
Changmao Biochemical Engineering Company Limited is a Hong Kong-based investment holding company principally engaged in the production and sales of organic acids. The main products of the Company include organic acids and their derivatives with four carbons in structures. Its products include fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L-tartaric acid, D-tartaric acid, DL-tartaric acid, L-aspartic acid and aspartame. Its products are mainly sold to food additive industries, chemical industries and pharmaceutical industries. The Company operates businesses in Mainland China, Europe, Asia Pacific, America and other regions.
More about the company